An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza viruses

Journal of Virology

Volumn 84, Issue 16, 2010, Pages 8275-8286

  Oh, Hsueh Ling Janice ^a   Åkerström, Sara ^c,d   Shen, Shuo ^a   Bereczky, Sándor ^c,d   Karlberg, Helen ^c,d   Klingström, Jonas ^c,d   Lal, Sunil K ^e   Mirazimi, Ali ^c,d   Tan, Yee Joo ^a,b  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; EPITOPE; HEMAGGLUTININ; MONOCLONAL ANTIBODY; PROTEIN SUBUNIT;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; GENETIC CONSERVATION; IMMUNOPRECIPITATION; INFLUENZA VIRUS A H5N1; NONHUMAN; NUCLEOTIDE SEQUENCE; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BODY WEIGHT; CONSERVED SEQUENCE; CROSS PROTECTION; CROSS REACTIONS; EPITOPE MAPPING; EPITOPES; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE INFECTIONS; SURVIVAL ANALYSIS; VIRUS INTERNALIZATION;

AVIAN INFLUENZA VIRUS; MUS; ORTHOMYXOVIRIDAE;

EID: 77955011794     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02593-09     Document Type: Article

References (48)

1. Beigel, J., and M. Bray. 2008. Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res. 78:91-102.
2. Beigel, J. H., J. Farrar, A. M. Han, F. G. Hayden, R. Hyer, M. D. de Jong, S. Lochindarat, T. K. Nguyen, T. H. Nguyen, T. H. Tran, A. Nicoll, S. Touch, and K. Y. Yuen. 2005. Avian influenza A (H5N1) infection in humans. N. Engl. J. Med. 353:1374-1385.
3. Cauthen, A. N., D. E. Swayne, S. Schultz-Cherry, M. L. Perdue, and D. L. Suarez. 2000. Continued circulation in China of highly pathogenic avian influenza viruses encoding the hemagglutinin gene associated with the 1997 H5N1 outbreak in poultry and humans. J. Virol. 74:6592-6599.
4. Chen, H., G. J. Smith, K. S. Li, J. Wang, X. H. Fan, J. M. Rayner, D. Vijaykrishna, J. X. Zhang, L. J. Zhang, C. T. Guo, C. L. Cheung, K. M. Xu, L. Duan, K. Huang, K. Qin, Y. H. Leung, W. L. Wu, H. R. Lu, Y. Chen, N. S. Xia, T. S. Naipospos, K. Y. Yuen, S. S. Hassan, S. Bahri, T. D. Nguyen, R. G. Webster, J. S. Peiris, and Y. Guan. 2006. Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc. Natl. Acad. Sci. U. S. A. 103:2845-2850.
5. Cheung, C. L., J. M. Rayner, G. J. Smith, P. Wang, T. S. Naipospos, J. Zhang, K. Y. Yuen, R. G. Webster, J. S. Peiris, Y. Guan, and H. Chen. 2006. Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J. Infect. Dis. 193:1626-1629.
6. Claas, E. C., J. C. de Jong, R. van Beek, G. F. Rimmelzwaan, and A. D. Osterhaus. 1998. Human influenza virus A/HongKong/156/97 (H5N1) infection. Vaccine 16:977-978. (Pubitemid 28276010)
7. Claas, E. C., A. D. Osterhaus, R. van Beek, J. C. De Jong, G. F. Rimmelzwaan, D. A. Senne, S. Krauss, K. F. Shortridge, and R. G. Webster. 1998. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351:472-477.
8. Connor, R. I., B. K. Chen, S. Choe, and N. R. Landau. 1995. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206:935-944.
9. Cox, M. M., P. A. Patriarca, and J. Treanor. 2008. FluBlok, a recombinant hemagglutinin influenza vaccine. Influenza Other Respi. Viruses 2:211-219.
10. Eckert, D. M., and P. S. Kim. 2001. Mechanisms of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 70:777-810.
11. Edwards, M. J., and N. J. Dimmock. 2001. Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event. J. Virol. 75:10208-10218.
12. Ekiert, D. C., G. Bhabha, M. A. Elsliger, R. H. Friesen, M. Jongeneelen, M. Throsby, J. Goudsmit, and I. A. Wilson. 2009. Antibody recognition of a highly conserved influenza virus epitope. Science 324:246-251.
13. Fouchier, R., T. Kuiken, G. Rimmelzwaan, and A. Osterhaus. 2005. Global task force for influenza. Nature 435:419-420.
14. Fraczkiewicz, R., and W. Braun. 1998. Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules. J. Comput. Chem. 19:319-333.
15. Gocník, M., T. Fislova, V. Mucha, T. Sladkova, G. Russ, F. Kostolansky, and E. Vareckova. 2008. Antibodies induced by the HA2 glycopolypeptide of influenza virus haemagglutinin improve recovery from influenza A virus infection. J. Gen. Virol. 89:958-967.
16. Graves, P. N., J. L. Schulman, J. F. Young, and P. Palese. 1983. Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants. Virology 126:106-116.
17. Hanson, B. J., A. C. Boon, A. P. Lim, A. Webb, E. E. Ooi, and R. J. Webby. 2006. Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice. Respir. Res. 7:126.
18. Huang, H., H. Dan, Y. Zhou, Z. Yu, H. Fan, T. Tong, M. Jin, and H. Chen. 2007. Different neutralization efficiency of neutralizing monoclonal antibodies against avian influenza H5N1 virus to virus strains from different hosts. Mol. Immunol. 44:1052-1055.
19. Kaverin, N. V., I. A. Rudneva, E. A. Govorkova, T. A. Timofeeva, A. A. Shilov, K. S. Kochergin-Nikitsky, P. S. Krylov, and R. G. Webster. 2007. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J. Virol. 81:12911-12917.
20. Kaverin, N. V., I. A. Rudneva, N. A. Ilyushina, N. L. Varich, A. S. Lipatov, Y. A. Smirnov, E. A. Govorkova, A. K. Gitelman, D. K. Lvov, and R. G. Webster. 2002. Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants. J. Gen. Virol. 83:2497-2505.
21. Kiso, M., K. Mitamura, Y. Sakai-Tagawa, K. Shiraishi, C. Kawakami, K. Kimura, F. G. Hayden, N. Sugaya, and Y. Kawaoka. 2004. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364:759-765. (Pubitemid 39165094)
22. Kiss, I., P. Gyarmati, S. Zohari, K. W. Ramsay, G. Metreveli, E. Weiss, M. Brytting, M. Stivers, S. Lindstrom, A. Lundkvist, K. Nemirov, P. Thoren, M. Berg, G. Czifra, and S. Belak. 2008. Molecular characterization of highly pathogenic H5N1 avian influenza viruses isolated in Sweden in 2006. Virol. J. 5:113.
23. Leslie, M. 2009. Immunology. Flu antibodies stir new hope for treatment, vaccine. Science 323:1160.
24. Lim, A. P., S. K. Wong, A. H. Chan, C. E. Chan, E. E. Ooi, and B. J. Hanson. 2008. Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1. Virol. J. 5:80.
25. Lipatov, A. S., E. A. Govorkova, R. J. Webby, H. Ozaki, M. Peiris, Y. Guan, L. Poon, and R. G. Webster. 2004. Influenza: emergence and control. J. Virol. 78:8951-8959.
26. Lu, J., Z. Guo, X. Pan, G. Wang, D. Zhang, Y. Li, B. Tan, L. Ouyang, and X. Yu. 2006. Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab′ice. Respir. Res. 7:43.
27. Luke, T. C., E. M. Kilbane, J. L. Jackson, and S. L. Hoffman. 2006. Metaanalysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann. Intern. Med. 145:599-609.
28. Marasco, W. A., and J. Sui. 2007. The growth and potential of human antiviral monoclonal antibody therapeutics. Nat. Biotechnol. 25:1421-1434.
29. Mayrhofer, J., S. Coulibaly, A. Hessel, G. W. Holzer, M. Schwendinger, P. Bruhl, M. Gerencer, B. A. Crowe, S. Shuo, W. Hong, Y. J. Tan, B. Dietrich, N. Sabarth, H. Savidis-Dacho, O. Kistner, P. N. Barrett, and F. G. Falkner. 2009. Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protection. J. Virol. 83:5192-5203.
30. Narasaraju, T., M. K. Sim, H. H. Ng, M. C. Phoon, N. Shanker, S. K. Lal, and V. T. Chow. 2009. Adaptation of human influenza H3N2 virus in a mouse pneumonitis model: insights into viral virulence, tissue tropism and host pathogenesis. Microbes Infect. 11:2-11.
31. Ray, K., V. A. Potdar, S. S. Cherian, S. D. Pawar, S. M. Jadhav, S. R. Waregaonkar, A. A. Joshi, and A. C. Mishra. 2008. Characterization of the complete genome of influenza A (H5N1) virus isolated during the 2006 outbreak in poultry in India. Virus Genes 36:345-353.
32. Salzberg, S. L., C. Kingsford, G. Cattoli, D. J. Spiro, D. A. Janies, M. M. Aly, I. H. Brown, E. Couacy-Hymann, G. M. De Mia, D. H. Dung, A. Guercio, T. Joannis, A. S. Maken Ali, A. Osmani, I. Padalino, M. D. Saad, V. Savic, N. A. Sengamalay, S. Yingst, J. Zaborsky, O. Zorman-Rojs, E. Ghedin, and I. Capua. 2007. Genome analysis linking recent European and African influenza (H5N1) viruses. Emerg. Infect. Dis. 13:713-718.
33. Sawyer, L. A. 2000. Antibodies for the prevention and treatment of viral diseases. Antiviral Res. 47:57-77.
34. Shen, S., G. Mahadevappa, H. L. Oh, B. Y. Wee, Y. W. Choi, L. A. Hwang, S. G. Lim, W. Hong, S. K. Lal, and Y. J. Tan. 2008. Comparing the antibody responses against recombinant hemagglutinin proteins of avian influenza A (H5N1) virus expressed in insect cells and bacteria. J. Med. Virol. 80:1972-1983.
35. Skehel, J. J., and D. C. Wiley. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:531-569.
36. Stevens, J., O. Blixt, T. M. Tumpey, J. K. Taubenberger, J. C. Paulson, and I. A. Wilson. 2006. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312:404-410.
37. Subbarao, K., A. Klimov, J. Katz, H. Regnery, W. Lim, H. Hall, M. Perdue, D. Swayne, C. Bender, J. Huang, M. Hemphill, T. Rowe, M. Shaw, X. Xu, K. Fukuda, and N. Cox. 1998. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279:393-396.
38. Sui, J., W. C. Hwang, S. Perez, G. Wei, D. Aird, L. M. Chen, E. Santelli, B. Stec, G. Cadwell, M. Ali, H. Wan, A. Murakami, A. Yammanuru, T. Han, N. J. Cox, L. A. Bankston, R. O. Donis, R. C. Liddington, and W. A. Marasco. 2009. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16:265-273.
39. Wang, S. F., K. H. Chen, A. Thitithanyanont, L. Yao, Y. M. Lee, Y. J. Chan, S. J. Liu, P. Chong, W. T. Liu, J. C. Huang, and Y. M. Chen. 2009. Generating and characterizing monoclonal and polyclonal antibodies against avian H5N1 hemagglutinin protein. Biochem. Biophys. Res. Commun. 382:691-696.
40. Wang, W., E. N. Butler, V. Veguilla, R. Vassell, J. T. Thomas, M. Moos, Jr., Z. Ye, K. Hancock, and C. D. Weiss. 2008. Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies. J. Virol. Methods 153:111-119.
41. WHO. March 2009, revision date. Continuing progress towards a unified nomenclature system for the highly pathogenic H5N1 avian influenza viruses. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/disease/ avian-influenza/guidelines/nomenclature/en/index.html.
42. WHO. 24 September 2009, posting date. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/disease/avian- influenza/country/cases-table-2009-09-24/en/index.html.
43. Wu, W. L., Y. Chen, P. Wang, W. Song, S. Y. Lau, J. M. Rayner, G. J. Smith, R. G. Webster, J. S. Peiris, T. Lin, N. Xia, Y. Guan, and H. Chen. 2008. Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007. J. Virol. 82:1798-1807.
44. Xu, X., K. Subbarao, N. J. Cox, and Y. Guo. 1999. Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology 261:15-19. (Pubitemid 29395053)
45. Yen, H. L., A. S. Monto, R. G. Webster, and E. A. Govorkova. 2005. Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. J. Infect. Dis. 192:665-672.
46. Zhang, S., L. Xiao, H. Zhou, Z. Yu, H. Chen, A. Guo, and M. Jin. 2008. Generation and characterization of an H5N1 avian influenza virus hemagglutinin glycoprotein pseudotyped lentivirus. J. Virol. Methods 154:99-103.
47. Zhou, B., N. Zhong, and Y. Guan. 2007. Treatment with convalescent plasma for influenza A (H5N1) infection. N. Engl. J. Med. 357:1450-1451.
48. Zohari, S., P. Gyarmati, P. Thoren, G. Czifra, C. Brojer, S. Belak, and M. Berg. 2008. Genetic characterization of the NS gene indicates co-circulation of two sub-lineages of highly pathogenic avian influenza virus of H5N1 subtype in Northern Europe in 2006. Virus Genes 36:117-125.